Latest News Archive
Please select Category, Year, and then Month to display items
23 November 2022
|
Story André Damons
![]()
Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.
The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.
The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS.
Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
First lecture in Law Dean's series presented
2010-10-22
 |
Prof. Johan Henning, Dean of the Faculty of Law at the UFS and Prof. Johan Farrar, a well respected Corporate Law Specialist, at the recent first lecture in the Law Dean’s Prestige Lecture Series.
Photo: Lize du Plessis
|
| Prof. John Farrar, a well respected Corporate Law Specialist of high international repute, delivered the first lecture in the Law Dean’s Prestige Lecture Series at the University of the Free State (UFS). The theme of his paper was Directors’ duties of care – Issues of classification, solvency and business judgement and the dangers of legal transplants.
The topic is of the utmost importance to South African lawyers in view of the very contentious provisions of the new Companies Act 71 of 2008 endeavouring to introduce the business judgement rule into South African Company Law if and thus reforming company directors’ common law duties of care and skill, if when this legislation at long last becomes operative.
Prof. Farrar is a professor of Corporate Governance at the University of Auckland Business School, and joint director of the New Zealand Governance Centre. These are part-time roles and the remainder of his time is spent as emeritus professor of Law at Bond University, Queensland.
Prof. Farrar has extensive experience in Commercial Law Reform, having, for example, acted as a consultant to the New Zealand Treasury, the Law Commission, the Business Council of Australia and the UK Department of Trade and Industry.
|